Violeta Panavienė

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

Alessandro Consolaro, Gabriella Giancane, Alessandra Alongi et al. · The Lancet Child & Adolescent Health · 2019 · 214 citations · Full text

Medicine, Child Health, Pediatrics +16

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

Gerd Horneff, Rubén Burgos‐Vargas, Tamás Constantin et al. · Annals of the Rheumatic Diseases · 2013 · 137 citations · Full text

Life Sciences, Genetics, Microbiology +17

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial

Hermine I. Brunner, Nicolino Ruperto, Nikolay Tzaribachev et al. · Annals of the Rheumatic Diseases · 2017 · 128 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +11

Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries

Joost F. Swart, Gabriella Giancane, Gerd Horneff et al. · Arthritis Research & Therapy · 2018 · 109 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis

Chiara Trincianti, E. H. Pieter van Dijkhuizen, Alessandra Alongi et al. · Arthritis & Rheumatology · 2021 · 97 citations · Full text

Medicine, Clinical Sciences, Pediatrics +15